CIK 0000890821 · Non-accelerated filer<br>Smaller reporting company
Enveric Biosciences, Inc.
Sign in to watch- Ticker
- ENVB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954484725
- Phone
- (617) 444-8400
- Business address
- 245 FIRST STREET RIVERVIEW II 18TH FLOOR, CAMBRIDGE, MA, 02142
- Former names
- AMERI Holdings, Inc., SPATIALIZER AUDIO LABORATORIES INC
- 4 Grant or award Director acquired 170,000 shares (grant or award)
- 4 Other acquisition Director acquired 31,523 shares (other)
- 4 Other acquisition Director acquired 8,710 shares (other)
- 4 Other acquisition Chief Executive Officer acquired 85,003 shares (other)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Option exercise Director acquired 7,680 shares (option exercise)
- 4 Option exercise Director acquired 9,063 shares (option exercise)
- 4 Option exercise Director acquired 7,680 shares (option exercise)
- 4 Option exercise Director acquired 9,985 shares (option exercise)
- 4 Option exercise Director acquired 9,524 shares (option exercise)
- 4 Option exercise Director acquired 8,602 shares (option exercise)
- 4 Option exercise Director acquired 333,333 shares (option exercise)
- 4 Open-market buy President & CEO bought 12,121 shares at $4.12 ($49,878)
- 4 Open-market buy Director bought 100,000 shares at $4.12 ($411,500)
- 4 Open-market buy Director bought 145,450 shares at $4.12 ($598,527)
- 4 Open-market buy Director bought 3,803 shares at an average $6.50 ($24,719)
- 4 Option exercise Director acquired 1,205,837 shares (option exercise)
- 4 Open-market buy Director bought 7,500 shares at $6.50 ($48,750)
- 4 Open-market buy Director bought 2,604 shares at $6.50 ($16,924)
Page 6 of 12 · 234 filings